European Centre for Disease Prevention and Control
An agency of the European Union
Yellow fever risk areas, as of 30 January 2019
Adapted from WHO Yellow Fever Vaccination Recommendations in the Americas, 2018
WHO Yellow Fever Vaccination Recommendations in the Americas (interactive map)
Yellow fever (YF) cause a wide spectrum of symptoms, from mild to fatal. In severe cases there may be spontaneous haemorrhage. Mortality of these clinical cases can be as high as 80%, on a par with Ebola, Marburg and other haemorrhagic viral infections.
5 Oct 2018 -
In 2016, there were no reported cases of yellow fever in EU/EEA countries.
No cases of yellow fever were reported in EU/EEA countries. Vaccination is the most important preventive measure against yellow fever. Latest data from the ECDC Annual epidemiological report.